A disease like cancer can
be a mortal battle, often fraught with overwhelming stress. Given that
stress management can be difficult even under ordinary circumstances,
elevated feelings of anxiety and depression in cancer patients are
certainly understandable.
Yet, several recent studies underscore how critically important it is for those fighting illness to learn how to combat stress.
A team of researchers led
by Lorenzo Cohen, professor of general oncology and director of the
Integrative Medicine Program at The University of Texas MD Anderson
Cancer Center, found that symptoms of depression among a group of
patients with late-stage renal cell carcinoma were associated with an
increased risk of death. The study was published in the journal PLOS ONE in August.
The chief suspects in Cohen's study: cortisol -- also known as the "stress hormone" -- and inflammatory pathways.
"This study is the next
step in the process of understanding that emotional factors have an
impact on biology, which can, in turn, influence outcomes in cancer,"
says Cohen.
Cortisol is the hormone
produced by the adrenal gland in response to stress. It helps regulate
the inflammatory response in the body.
According to Cohen, under
normal circumstances cortisol levels should be high in the morning and
drop throughout the course of the day. But among patients experiencing
chronic stress or depressive symptoms, cortisol levels can remain
sustained throughout the day, with less of a decrease in the evening.
In the study, those
patients with sustained cortisol levels throughout the day had an
increased risk of mortality. Through gene profile analyses of patients,
the researchers documented that the association between patient
psychological condition and survival time may stem from a dysregulation
in inflammatory biology.
Two other studies on how stress influences other illnesses shed further light on this process.
A team of researchers
led by Sheldon Cohen (not related to Lorenzo Cohen), professor of
psychology and director of the Laboratory for the Study of Stress,
Immunity and Disease at Carnegie Mellon University, found that chronic
psychological stress was associated with the body losing its ability to
regulate its inflammatory response.
The researchers found
that over a prolonged period of chronic stress, body tissue becomes
desensitized to cortisol and the hormone loses its effectiveness in
regulating inflammation.
Inflammation is a good thing when it's triggered as part of the body's
effort to fight infection, says Lorenzo Cohen, but chronic inflammation
can promote the development and progression of many illnesses, including
depression, heart disease, rheumatoid arthritis, diabetes and cancer.
One of the challenges in
this type of research is that causation between psychological stress
and cancer survival is notoriously hard to pin down. You cannot, after
all, ethically heckle a group of cancer patients just to monitor their
stress response.
But a growing body of
research from scientists studying ovarian, breast and other cancers
continues to cement the link between psychological stress and disease,
metastatic growth and survival.
It also suggests that stress management should be an integral part of
the treatment for cancer and perhaps even all inflammatory diseases.
According to Lorenzo
Cohen, the next step is to conduct clinical trials by taking a
population of cancer patients who meet the criteria for depression and
anxiety, treating their mood disorders and seeing whether outcomes are
improved, compared to a control group that does not receive the same
treatment.
In the meantime, Cohen urges cancer patients to try to manage in some fashion the stress associated with a life with cancer.
For some individuals,
that may mean turning to psychiatry or cognitive behavioral therapy or
perhaps a more pharmacological approach, he says.
Yet others may turn to
mind-body medicine and consider practices such as meditation, yoga, tai
chi, self-hypnosis or guided imagery -- all of which have been shown to
be quite useful in helping to manage stress.
Managing stress,
alongside conventional treatment and a full lifestyle programmatic
approach, may ultimately improve outcomes, says Cohen.
"We certainly know it
improves patient's quality of life. Now we need to do more research to
see if modifying diet, increasing physical activity and managing stress
can also prolong survival."
No comments:
Post a Comment